LIMG
LIMITATION OF GOODS RECEIVED FROM IB
05/09/2025
Voltar para busca
Dado oficial do USPTO
NEOCELLA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
06/09/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
02/12/2022
Data de registro
27/08/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/08/2024
Última transação
06/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
US
Examinador
SEGAL, MOLLY
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
NEOCELLA INC.
Representantes
Kisuk Lee Harness, Dickey & Pierce, PLC
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Veterinary preparations for oncologycancers; vaccines; non-prescription medicines for oncologycancers; contrast media for in vivo imaging; radioactive pharmaceutical preparations for in vivo diagnostics and therapeutic use; pharmaceutical preparations for the prevention of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of cardiovascular disease; drug delivery agents in the form of biologicscapsuletablet; drug delivery agents that facilitate the delivery of pharmaceutical preparations; diagnostic agents for medical purposes; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the treatment of inflammatory diseases; contrast media for use in medical imaging; biological preparations for medical or veterinary purposesfor the treatment of cancer; diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; in vitro diagnostic preparations for medical purposes; antibodies for medical purposes; Pharmaceutical preparations for oncology and precision medicinecancer; radioisotope markers for therapeutic or diagnostic use
Classe 42
Cell separation research services; development of cell therapy products; drug discovery services; research to develop new products in the field of oncology and precision medicinecancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testinginspection and research services in the fields of pharmaceuticalscosmetics and foodstuffs; Pharmaceutical drug development; pharmaceutical research services; consultancy relating to pharmaceutical research and development; research relating to pharmaceuticals; pharmaceutical drug development services; consultancy pertaining to pharmacology; medicine research; stem cell research services; DNA analysis for scientific research purposes; consultation and providing information in the field of biomedicine research and development; research relating to crude drugs; biochemical analysis; clinical research in the field of medicine; scientific research services for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/03/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/02/2025
FIMP
FINAL DISPOSITION PROCESSED
13/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/11/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/08/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
27/08/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
17/08/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/07/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/06/2024
PUBO
PUBLISHED FOR OPPOSITION
11/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/05/2024
DOCK
ASSIGNED TO EXAMINER
08/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/03/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/03/2024
RFNT
REFUSAL PROCESSED BY IB
25/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/10/2023
RFRR
REFUSAL PROCESSED BY MPU
02/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/09/2023
CNRT
NON-FINAL ACTION WRITTEN
19/09/2023
DOCK
ASSIGNED TO EXAMINER
12/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEOCELLA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.